Follow
Ahmed O. Hassan
Title
Cited by
Cited by
Year
Potently neutralizing and protective human antibodies against SARS-CoV-2
SJ Zost, P Gilchuk, JB Case, E Binshtein, RE Chen, JP Nkolola, A Schäfer, ...
Nature 584 (7821), 443-449, 2020
10502020
A SARS-CoV-2 infection model in mice demonstrates protection by neutralizing antibodies
AO Hassan, JB Case, ES Winkler, LB Thackray, NM Kafai, AL Bailey, ...
Cell 182 (3), 744-753. e4, 2020
5162020
A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2
AO Hassan, NM Kafai, IP Dmitriev, JM Fox, BK Smith, IB Harvey, RE Chen, ...
Cell 183 (1), 169-184. e13, 2020
4982020
A potently neutralizing antibody protects mice against SARS-CoV-2 infection
WB Alsoussi, JS Turner, JB Case, H Zhao, AJ Schmitz, JQ Zhou, RE Chen, ...
The Journal of Immunology 205 (4), 915-922, 2020
1802020
A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters
TL Bricker, TL Darling, AO Hassan, HH Harastani, A Soung, X Jiang, ...
Cell reports 36 (3), 2021
1402021
A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques
AO Hassan, F Feldmann, H Zhao, DT Curiel, A Okumura, TL Tang-Huau, ...
Cell Reports Medicine 2 (4), 2021
1192021
An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
AO Hassan, S Shrihari, MJ Gorman, B Ying, D Yuan, S Raju, RE Chen, ...
Cell reports 36 (4), 2021
972021
Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals
SJ Zost, P Gilchuk, JB Case, E Binshtein, RE Chen, JX Reidy, A Trivette, ...
BioRxiv, 2020.05. 22.111005, 2020
622020
A gorilla adenovirus-based vaccine against Zika virus induces durable immunity and confers protection in pregnancy
AO Hassan, IP Dmitriev, EA Kashentseva, H Zhao, DE Brough, ...
Cell reports 28 (10), 2634-2646. e4, 2019
262019
Adenoviral L4 33K forms ring-like oligomers and stimulates ATPase activity of IVa2: implications in viral genome packaging
YS Ahi, SV Vemula, AO Hassan, G Costakes, C Stauffacher, SK Mittal
Frontiers in microbiology 6, 318, 2015
252015
Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses
AO Hassan, O Amen, EE Sayedahmed, SV Vemula, S Amoah, I York, ...
PLoS One 12 (10), e0186244, 2017
202017
Longevity of adenovirus vector immunity in mice and its implications for vaccine efficacy
EE Sayedahmed, R Kumari, S Shukla, AO Hassan, SI Mohammed, ...
Vaccine 36 (45), 6744-6751, 2018
192018
A highly immunogenic vaccine against A/H7N9 influenza virus
W Cao, JS Liepkalns, AO Hassan, RP Kamal, AR Hofstetter, S Amoah, ...
Vaccine 34 (6), 744-749, 2016
172016
Isolation and molecular characterisation of a pestivirus from goats in Egypt
A Abdel-Latif, S Goyal, Y Chander, A Abdel-Moneim, S Tamam, ...
Acta Veterinaria Hungarica 61 (2), 270-280, 2013
172013
A bovine adenoviral vector-based H5N1 influenza-vaccine provides enhanced immunogenicity and protection at a significantly low dose
EE Sayedahmed, AO Hassan, R Kumari, W Cao, S Gangappa, I York, ...
Molecular Therapy-Methods & Clinical Development 10, 210-222, 2018
162018
Adenoviral E4 34K protein interacts with virus packaging components and may serve as the putative portal
YS Ahi, AO Hassan, SV Vemula, K Li, W Jiang, GJ Zhang, SK Mittal
Scientific reports 7 (1), 7582, 2017
152017
A single intranasal dose of chimpanzee adenovirus-vectored vaccine confers sterilizing immunity against SARS-CoV-2 infection
AO Hassan, NM Kafai, IP Dmitriev, JM Fox, B Smith, IB Harvey, RE Chen, ...
BioRxiv, 2020.07. 16.205088, 2020
62020
155R is a novel structural protein of bovine adenovirus type 3, but it is not essential for virus replication
AO Hassan, SV Vemula, A Sharma, DS Bangari, KK Mishra, SK Mittal
Journal of General Virology 98 (4), 749-753, 2017
32017
Recombinant Adenovirus Vector-Based Vaccines for Emerging Influenza Viruses
AO Hassan
2017
The system can't perform the operation now. Try again later.
Articles 1–19